Mirae Asset Global ETFs Holdings’s NewAmsterdam Pharma NAMS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$647K	Buy	19,099 +1,234	+7%	+$40.7K	﹤0.01%	1864
2026 Q1	$572K	Sell	17,865 -705	-4%	-$23K	﹤0.01%	1821
2025 Q4	$651K	Sell	18,570 -7,366	-28%	-$268K	﹤0.01%	1758
2025 Q3	$738K	Sell	25,936 -5,447	-17%	-$131K	﹤0.01%	1675
2025 Q2	$568K	Buy	31,383 +1,604	+5%	+$29.3K	﹤0.01%	1757
2025 Q1	$610K	Buy	+29,779	New	+$662K	﹤0.01%	1760

Other funds holding NAMS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NAMS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its NewAmsterdam Pharma (NAMS) stake by 6.9% in Q2 2026, buying an estimated $40.7K and bringing the position to 19,099 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #1864.

Mirae Asset Global ETFs Holdings first reported a position in NAMS in Q1 2025 and has held it in 6 quarters since. The position peaked at $738K in Q3 2025. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

Mirae Asset Global ETFs Holdings held 19,099 shares of NewAmsterdam Pharma worth $647K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 1,234 NewAmsterdam Pharma shares in Q2 2026, an estimated $40.7K.
NewAmsterdam Pharma made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1864 holding.
Mirae Asset Global ETFs Holdings first reported a position in NewAmsterdam Pharma in Q1 2025 and has held it in 6 quarters since.
Mirae Asset Global ETFs Holdings's NewAmsterdam Pharma position peaked at $738K in Q3 2025.
194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.